Both in Pharmaceuticals
Clene vs Xilio Therapeutics
Over the past year CLNN returned −62.5% and XLO returned −22.4%; their daily moves had a correlation of -0.03.
CLNN −62.5% XLO −22.4%Growth of $1, one year, split-adjusted
| Metric | CLNN | XLO |
|---|---|---|
| Price | $4.10 | $8.71 |
| Market cap | $58.3M | $57.3M |
| Today | +8.75% | +0.35% |
| 1 month | +5.9% | −3.2% |
| 6 months | −42.7% | +10.3% |
| Year to date | −30.2% | −2.8% |
| 1 year | −65.8% | −26.8% |
| Revenue growth (YoY) | +233.3% | +131.2% |
| Gross margin | 60.0% | 100.0% |
| Net margin | −14915.6% | −34.1% |
| P/E (TTM) | — | — |
| Price / sales | 295.8× | 0.9× |
| Net cash | -$9.1M | $136.0M |
| Dividend yield | — | — |
| Volatility (60d) | 77.9% | 38.3% |
| Short % of float | 4.6% | 10.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).